why choose us

First received: June 12, 2023

Clinical Trial: Post-COVID-19 Mucormycosis in Critical Care

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Mucormycosis; Rhinocerebral (Etiology)

Study Type: OBSERVATIONAL


Official Title: Post COVID-19 Acute Mucormycosis in Critical Care Settings in Egypt: A Single-Center Experience

Brief Summary: Background: Mucormycosis is a life-threatening opportunistic fungal infection.Despite mucormycosis having existed for decades, it has gained notice of its widespread in many parts of the world during the second wave of the coronavirus disease 2019 (COVID-19) pandemic.The study aimed to determine the in-hospital outcomes of post-COVID-19 mucormycosis during the intensive care unit (ICU) stay in Egypt.Methods: This prospective cohort study included all patients admitted to the Medical ICU of the University Hospital…

Read more